As we mark Gout Awareness Day on May 22, 2023, Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd., a clinical stage biotechnology company, is calling for increased understanding of this disabling and potentially life threatening condition.
Through a special video released by the company, they are shedding light on the causes of gout, the severe and sometimes deadly complications that can result, and their ongoing progress in developing a new, life-saving treatment. Let’s take this opportunity to spread the word about gout and its effects, and lend our support to all who suffer from this devastating illness.
Gout is a condition that can cause excruciating pain and can lead to permanent joint damage, heart attacks, and kidney disease. At Atom Bioscience we strive to do more than just manage the painful symptoms associated with gout flare-ups, and instead focus on targeting the root cause – excessive levels of uric acid in the bloodstream. To achieve this, we need to reduce the serum uric acid levels to 5mg/dL. It’s a challenging endeavor, but it’s worth it for the patient’s long-term health.
Gout is a growing problem facing the world today: with over 55 million people affected, its prevalence is only increasing year over year. Americans are particularly hard hit, with over 9.3 million individuals affected; what’s more, the U.S. health care system spends billions of dollars on treating gout each year. It’s time for everyone to take action to mitigate the spread of this condition.
Gout is an incredibly common type of inflammatory arthritis, the result of a built-up of uric acid levels in the blood which is caused by genetic mutations in uric acid transport disorders. By having a level of uric acid that is greater than 7 mg/dL, an individual is considered to have a hyperuricemia condition and is at risk of developing gout.
When the body’s transporters don’t do their job correctly, uric acid builds up in the body, creating a whole host of problems. Unnatural concentrations of uric acid can cause excruciatingly-painful inflammation in joints and soft tissues, and can also lead to the formation of urate kidney stones.
About Atom Bioscience
Atom Bioscience, a rapidly expanding drug developer, has come to the forefront in its small molecule therapeutics approach for treating inflammatory and metabolic diseases. ABP-671, the company’s cutting-edge lead product, is currently undergoing clinical trials for the cure of chronic gout. Atom Bioscience is focused on producing the most optimized and effective treatments for such ailments, firmly pushing the boundaries of what is possible in modern pharmaceuticals.